Trials / Completed
CompletedNCT01736631
Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder
Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Nova Scotia Health Authority · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We are doing this study to find out how well cognitive behavioural therapy for social phobia works in people with bipolar disorder, who also have social phobia.
Detailed description
Social phobia is a very prevalent anxiety disorder in people with bipolar disorder and is associated with adverse outcomes. Yet, social phobia is treatable by cognitive behavioural therapy or antidepressant medication. As antidepressants are often contra-indicated in people with bipolar disorder, cognitive behavioural therapy is the likely first choice treatment for social phobia in this population. However, people with bipolar disorder were excluded from previous clinical trials on treatment of social phobia. Our aim is to evaluate the acceptability and to provide a rough estimate of efficacy of cognitive behavioural therapy protocol for social phobia in people with bipolar disorder in a systematic case series. We will also prepare pilot data for evaluating the impact of treatment of comorbid social phobia on the long-term course of bipolar disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Cognitive behavioural therapy (CBT) | The CBT intervention will follow the model of social phobia by Clark \& Wells (Clark \& Wells, 1995; Clark, 2005). The main elements of CBT for social phobia include reducing self-focus, dropping safety behaviours, and testing negative cognitions. |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2019-01-24
- Completion
- 2022-09-09
- First posted
- 2012-11-29
- Last updated
- 2022-11-14
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01736631. Inclusion in this directory is not an endorsement.